S

Stoke Therapeutics

Develops targeted gene upregulation therapies

Senior Clinical Trial Manager

Clinical Research OperationsConfirmed live in the last 24 hours
Full-time

About the Job

Requirements

  • A bachelor's degree or higher in a scientific or healthcare discipline is preferred.
  • At least 8 years of progressive experience leading global pivotal clinical trials within the biotechnology, pharmaceutical, or contract research organization industry, or equivalent clinical research experience.
  • Experience managing and providing oversight to contract research organizations and vendors, ensuring delivery on time, with quality, and within budget.
  • Experience providing oversight review of pre-study visits, site initiation visits, interim monitoring visits, and close-out visits is required.
  • Strong knowledge of International Council for Harmonisation Good Clinical Practice guidelines and regulations.
  • Strong knowledge of the drug development process.
  • Proficiency with Microsoft Word, Excel, Outlook, PowerPoint, and Microsoft Project.
  • Ability to work independently and collaboratively in a fast-paced start-up environment with internal and external team members.
  • Analytical thinking and problem-solving skills, with the ability to adapt to changing priorities and deadlines.
  • Planning, organization, and time-management skills, including the ability to support and prioritize multiple projects.

Responsibilities

  • Lead cross-functional clinical study teams and manage all aspects of assigned studies, overseeing partner contract research organizations and vendors to ensure studies follow the protocol and Good Clinical Practice, and meet Clinical Development Plan timelines and budgets.
  • Lead or oversee study feasibility, site and country selection, and timely site activation.
  • Oversee vendor selection and qualification, and ensure vendors are set up correctly; ensure user acceptance testing is completed effectively where needed.
  • Provide input into clinical study protocols, informed consent forms, and other clinical study documents.
  • Oversee development of study operational plans to ensure study compliance and quality.
  • Oversee development of and adherence to clinical study timelines under the Clinical Development Plan and collaborate with internal functional stakeholders for alignment.
  • Proactively identify study risks and coordinate mitigation with the study team, contract research organizations, and vendors, escalating risks as needed.
  • Provide effective vendor and contract research organization oversight and ensure studies comply with the protocol and Good Clinical Practice.
  • Coordinate timely exchange of study status with internal functional stakeholders to support delivery under the Clinical Development Plan.
  • Coordinate with Chemistry, Manufacturing, and Controls on drug forecasting and drug-product supply to sites.
  • Support timely and efficient database locks, including interim locks, by ensuring monitoring plans are in place and participating in data review and reconciliation.
  • Follow the clinical study budgeting process and provide budget accrual and forecast input to Finance.
  • Participate in study scenario planning by estimating timelines and costs; apply project-management skills to ensure process consistency and improve Clinical Operations performance.
  • Ensure the Trial Master File meets inspection-readiness requirements.
  • Provide and review study dashboards with the cross-functional team.
  • Participate in department initiatives, including developing and defining standard operating procedures and processes.

Desired Qualifications

  • Rare-disease and pediatric experience is preferred but not required.
  • Pediatric rare-disease and neurology clinical study experience is highly desirable.
  • Experience with dose-escalation or dose-finding studies that include a Safety Monitoring Committee is desirable.

About the Company

Stoke Therapeutics

Develops targeted gene upregulation therapies

Stoke Therapeutics develops therapies for severe genetic diseases caused by loss of function in a single gene, aiming to restore missing proteins by upregulating protein expression. Its main product approach relies on the TANGO (Targeted Augmentation of Nuclear Gene Output) platform, which delivers precise, durable, and controllable upregulation of gene expression across a range of tissues to re-create the missing protein. Compared with many biotech firms, Stoke centers on upregulating endogenous gene output rather than replacing genes or adding new ones, and focuses on disease-modifying treatments for rare disorders with unmet medical needs. Revenue comes from partnerships, licensing agreements, and, ultimately, commercialization of its therapies. The company’s goal is to provide targeted, durable treatments that address the underlying genetic deficiency and improve outcomes for patients with limited options.

Company size
201-500
Company stage
IPO
Headquarters
Bedford, TX
Founded
2014

Recently Posted Jobs

Explore more opportunities at Stoke Therapeutics

See more jobs